1. Home
  2. ETNB vs CBRL Comparison

ETNB vs CBRL Comparison

Compare ETNB & CBRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETNB
  • CBRL
  • Stock Information
  • Founded
  • ETNB 2018
  • CBRL 1969
  • Country
  • ETNB United States
  • CBRL United States
  • Employees
  • ETNB N/A
  • CBRL N/A
  • Industry
  • ETNB Biotechnology: Pharmaceutical Preparations
  • CBRL Restaurants
  • Sector
  • ETNB Health Care
  • CBRL Consumer Discretionary
  • Exchange
  • ETNB Nasdaq
  • CBRL Nasdaq
  • Market Cap
  • ETNB 1.5B
  • CBRL 1.3B
  • IPO Year
  • ETNB 2019
  • CBRL N/A
  • Fundamental
  • Price
  • ETNB $10.12
  • CBRL $66.88
  • Analyst Decision
  • ETNB Strong Buy
  • CBRL Hold
  • Analyst Count
  • ETNB 8
  • CBRL 8
  • Target Price
  • ETNB $26.43
  • CBRL $53.86
  • AVG Volume (30 Days)
  • ETNB 2.2M
  • CBRL 1.3M
  • Earning Date
  • ETNB 08-04-2025
  • CBRL 06-05-2025
  • Dividend Yield
  • ETNB N/A
  • CBRL 1.50%
  • EPS Growth
  • ETNB N/A
  • CBRL N/A
  • EPS
  • ETNB N/A
  • CBRL 2.58
  • Revenue
  • ETNB N/A
  • CBRL $3,510,062,000.00
  • Revenue This Year
  • ETNB N/A
  • CBRL $1.97
  • Revenue Next Year
  • ETNB N/A
  • CBRL $1.61
  • P/E Ratio
  • ETNB N/A
  • CBRL $25.94
  • Revenue Growth
  • ETNB N/A
  • CBRL 2.84
  • 52 Week Low
  • ETNB $4.16
  • CBRL $33.86
  • 52 Week High
  • ETNB $11.84
  • CBRL $68.09
  • Technical
  • Relative Strength Index (RSI)
  • ETNB 58.34
  • CBRL 65.36
  • Support Level
  • ETNB $9.45
  • CBRL $59.29
  • Resistance Level
  • ETNB $10.34
  • CBRL $68.08
  • Average True Range (ATR)
  • ETNB 0.52
  • CBRL 3.21
  • MACD
  • ETNB -0.07
  • CBRL 0.57
  • Stochastic Oscillator
  • ETNB 69.34
  • CBRL 91.51

About ETNB 89bio Inc.

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).

About CBRL Cracker Barrel Old Country Store Inc

Cracker Barrel Old Country Store Inc operates hundreds of full-service restaurants throughout the United States. The restaurants of the company are open for breakfast, lunch, and dinner, with menus that offer home-style country food. The company generates maximum revenue from the Restaurants.

Share on Social Networks: